feed,title,long_url,short_url
Benzinga,SciSparc Completes Development Of Its Proprietary Drug Candidate SCI-110 To Treat Tourette Syndrome,https://benzinga.com/general/biotech/22/06/27916993/scisparc-completes-development-of-its-proprietary-drug-candidate-sci-110-to-treat-tourette-syndro,https://bit.ly/3NMcd7z
